ScreenerHero

PBYI Puma Biotechnology, Inc.

NAS · US · Healthcare · Biotechnology · pumabiotechnology.com
9.810USD+3.26%Mkt Cap: 506.39M $P/E: 19.24

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of n…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap506.39M USD
Enterprise Value401.30M USD
Revenue (TTM)231.24M USD
Gross Profit170.21M USD
Net Income (TTM)31.11M USD
Revenue/Share4.57 USD
Last Price9.810 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees179
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)19.24
P/E (Forward)27.14
PEG—
EV/EBITDA10.00
EV/Revenue1.74
P/S2.12
P/B3.50
EPS (TTM)0.50
EPS (Forward)0.35
52W Range
4.50095% of range10.10
52W High10.10 USD
52W Low4.500 USD
Profitability
Gross Margin74.53%
Oper. Margin13.42%
EBITDA Margin17.35%
Profit Margin13.62%
ROE23.87%
ROA14.38%
Growth
Revenue Growth7.80%
Earnings Growth35.80%
Cash Flow & Leverage
Operating CF41.80M USD
CapEx (TTM)71.00K USD
FCF Margin14.04%
FCF Yield6.41%
Net Debt-89.09M USD
Net Debt/EBITDA-2.22
Balance Sheet
Debt/Equity0.22
Current Ratio2.91
Quick Ratio2.57
Book Value/Sh2.71 USD
Cash/Share1.82 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.51.62M
Float39.64M
Insiders15.28%
Institutions75.63%
Short Interest
Short Ratio14.6d
Short % Float9.80%
Short % Out.8.37%
Shares Short4.32M
Short (prev mo.)4.17M
Technical
SMA 509.067 (+8.2%)
SMA 2007.492 (+30.9%)
Beta1.21
S&P 52W Chg16.45%
Avg Vol (30d)320.55K
Avg Vol (10d)370.22K
Technical Indicators
RSI (14)57.5
MACD0.2120
MACD Signal0.2479
MACD Hist.-0.0360
BB Upper10.12 USD
BB Middle9.541 USD
BB Lower8.966 USD
BB Width12.06%
ATR (14)0.4182 USD
Vol Ratio (20d)1.16x